Mail-order access to a drug used in the most common form of abortion in the U.S. would end under a federal appeals court ruling issued Wednesday that cannot take effect until the Supreme Court weighs in.
The decision by three judges on the 5th U.S. Circuit Court of Appeals in New Orleans overturned part of a lower court ruling that would have revoked the Food and Drug Administration’s 23-year-old approval of mifepristone. But it left intact part of the ruling that would end the availability of the drug by mail, allow it to be used through only the seventh week of pregnancy rather than the 10th, and require that it be administered in the presence of a physician.
Those restrictions won’t take effect right away because the Supreme Court previously intervened to keep the drug available during the legal fight.
I-94 Permit Price Soars from $6 to $30 for Mexican Visitors Heading to Disneyland
One of the US’s most wanted criminals arrested in Guerrero
Who was Esmeralda FG, the TikToker who was murdered along with her husband and children in Guadalajara?
IMMIGRATION
Carlos Martínez: “It is an Honor to be Mexican, We Must Shout It From the Rooftops — We’re Going to be Okay.”
BUSINESS
Preparing for the Holiday Sales Rush: Logistics and E-commerce Strategy for Small Businesses
Why Salma Hayek’s husband is selling Puma? What Small Business Owners can Learn
Del Monte Foods Files Bankruptcy: When Is It the Right Time for a Business to Declare Bankruptcy?
Want to Be Your Own Boss? Don’t Fall Into the “Do-It-All” Trap